// App-Quantinova.ai

TCT CONNECT-385 : Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease: A Secondary Analysis From ORBITA

Researchers

Presenter

  • Christopher Rajkumar

Principal Investigators

  • Henry Seligman

  • Yousif Ahmad

  • Takayuki Warisawa

  • Christopher Cook

  • James Howard

  • Laura Amarin

  • Alexandra Nowbar

  • Michael Foley

  • Ravi Assomull

  • Niall Keenan

  • Joban Sehmi

  • Thomas Keeble

  • John Davies

  • Kare Tang

  • Robert Gerber

  • Graham Cole

  • Peter O'Kane

  • Andrew Sharp

  • Ramzi Khamis

  • Gajen Kanaganayagam

  • Ricardo Petraco

  • Neil Ruparelia

  • Iqbal Malik

  • Sukhjinder Nijjer

  • Sayan Sen

  • Darrel Francis

  • Rasha Al-Lamee

Medical Centers

  • Imperial College Hospital NHS trust, London, United Kingdom

  • Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom

  • Imperial College at Hammersmith Hospital, London, United Kingdom

  • University Hospital of Wales, Cardiff, United Kingdom

  • Essex Cardiothoracic Centre, Basildon, United Kingdom

  • National Heart and Lung Institute, London, United Kingdom

  • Imperial College London, San Francisco, California

  • HPB Medicine Unit, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom

  • Hammersmith Hospital NHS Trust, London, United Kingdom

  • West Hertfordshire Hospital, Watford, United Kingdom

  • East Sussex Healthcare NHS Trust, Hawkhurst, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Stable coronary artery disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Placebo Control

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved